SEOM clinical guidelines for the management of metastatic breast cancer 2013.

about

Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.

P2860

Q36938365-CB26BC20-2357-45F4-A81D-D46B73E4DD74 Q37560059-BEE88131-3C5B-463E-A70F-97684703A9E2

P2860

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

Item

http://www.wikidata.org/entity/Q46011982

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

@en

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

@nl

type

Item

label

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

@en

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

@nl

prefLabel

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

@en

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

@nl

P1476

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

@en

P2093

A Llombart Cussac

http://www.w3.org/2001/XMLSchema#string

A Ruiz Simón

http://www.w3.org/2001/XMLSchema#string

I Álvarez López

http://www.w3.org/2001/XMLSchema#string

J Cortés Castán

http://www.w3.org/2001/XMLSchema#string

J de la Haba Rodríguez

http://www.w3.org/2001/XMLSchema#string

SEOM

http://www.w3.org/2001/XMLSchema#string

P2860

Combination anastrozole and fulvestrant in metastatic breast cancer

The sequential use of endocrine treatment for advanced breast cancer: where are we?

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?

Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review.

The role of chemotherapy and targeted agents in patients with metastatic breast cancer.

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review.

1st International consensus guidelines for advanced breast cancer (ABC 1).

P2888

s12094-013-1095-0

P304

1004-1010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-013-1095-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258036713

http://www.w3.org/2001/XMLSchema#string

P698

24151043

http://www.w3.org/2001/XMLSchema#string

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

about

P2860

P2860

SEOM clinical guidelines for the management of metastatic breast cancer 2013.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698